Serveur d'exploration Tocilizumab - Exploration (Accueil)

Index « Auteurs » - entrée « Atsushi Kawakami »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Atsushi Kaneko < Atsushi Kawakami < Atsushi Kawashima  Facettes :

List of bibliographic references indexed by Atsushi Kawakami

Number of relevant bibliographic references: 31.
[20-40] [0 - 20][0 - 31]
Ident.Authors (with country if any)Title
002076 (2015) Shin-Ya Kawashiri [Japon] ; Takahisa Suzuki [Japon] ; Yoshikazu Nakashima [Japon] ; Yoshiro Horai [Japon] ; Akitomo Okada [Japon] ; Naoki Iwamoto [Japon] ; Kunihiro Ichinose [Japon] ; Mami Tamai [Japon] ; Kazuhiko Arima [Japon] ; Hideki Nakamura [Japon] ; Tomoki Origuchi [Japon] ; Masataka Uetani [Japon] ; Kiyoshi Aoyagi [Japon] ; Atsushi Kawakami [Japon]Confirmation of effectiveness of tocilizumab by ultrasonography and magnetic resonance imaging in biologic agent-naïve early-stage rheumatoid arthritis patients.
002788 (2013) Hideki Nakamura [Japon] ; Yukitaka Ueki ; Shigeki Saito ; Yoshiro Horai ; Takahisa Suzuki ; Tomoki Naoe ; Katsumi Eguchi ; Atsushi KawakamiDevelopment of adult T-cell leukemia in a patient with rheumatoid arthritis treated with tocilizumab.
003572 (2012) Ryoko Sakai [Japon] ; Michi Tanaka [Japon] ; Toshihiro Nanki [Japon] ; Kaori Watanabe [Japon] ; Hayato Yamazaki [Japon] ; Ryuji Koike [Japon] ; Hayato Nagasawa [Japon] ; Koichi Amano [Japon] ; Kazuyoshi Saito [Japon] ; Yoshiya Tanaka [Japon] ; Satoshi Ito [Japon] ; Takayuki Sumida [Japon] ; Atsushi Ihata [Japon] ; Yoshiaki Ishigatsubo [Japon] ; Tatsuya Atsumi [Japon] ; Takao Koike [Japon] ; Atsuo Nakajima [Japon] ; Naoto Tamura [Japon] ; Takao Fujii [Japon] ; Hiroaki Dobashi [Japon] ; Shigeto Tohma [Japon] ; Takahiko Sugihara [Japon] ; Yukitaka Ueki [Japon] ; Akira Hashiramoto [Japon] ; Atsushi Kawakami [Japon] ; Noboru Hagino [Japon] ; Nobuyuki Miyasaka [Japon] ; Masayoshi Harigai [Japon]Drug retention rates and relevant risk factors for drug discontinuation due to adverse events in rheumatoid arthritis patients receiving anticytokine therapy with different target molecules
003932 (2011) Shin-Ya Kawashiri [Japon] ; Atsushi Kawakami ; Naoki Iwamoto ; Keita Fujikawa ; Toshiyuki Aramaki ; Mami Tamai ; Satoshi Yamasaki ; Hideki Nakamura ; Tomoki Origuchi ; Yukitaka Ueki ; Kiyoshi Migita ; Akinari Mizokami ; Kiyoshi Aoyagi ; Katsumi EguchiIn rheumatoid arthritis patients treated with tocilizumab, the rate of clinical disease activity index (CDAI) remission at 24 weeks is superior in those with higher titers of IgM-rheumatoid factor at baseline.
003946 (2011) Shin-Ya Kawashiri [Japon] ; Atsushi Kawakami ; Naoki Iwamoto ; Keita Fujikawa ; Toshiyuki Aramaki ; Mami Tamai ; Satoshi Yamasaki ; Hideki Nakamura ; Yukitaka Ueki ; Kiyoshi Migita ; Akinari Mizokami ; Tomoki Origuchi ; Kiyoshi Aoyagi ; Katsumi EguchiDisease activity score 28 may overestimate the remission induction of rheumatoid arthritis patients treated with tocilizumab: comparison with the remission by the clinical disease activity index.
003C28 (2010) Shin-Ya Kawashiri [Japon] ; Atsushi Kawakami ; Naoki Iwamoto ; Keita Fujikawa ; Toshiyuki Aramaki ; Mami Tamai ; Kazuhiko Arima ; Kunihiro Ichinose ; Makoto Kamachi ; Satoshi Yamasaki ; Hideki Nakamura ; Tomoki Origuchi ; Hiroaki Ida ; Katsumi EguchiSwitching to the anti-interleukin-6 receptor antibody tocilizumab in rheumatoid arthritis patients refractory to antitumor necrosis factor biologics.
003E18 (2010) Shin-Ya Kawashiri [Japon] ; Atsushi Kawakami [Japon] ; Noriho Sakamoto [Japon] ; Yuji Ishimatsu [Japon] ; Katsumi Eguchi [Japon]A fatal case of acute exacerbation of interstitial lung disease in a patient with rheumatoid arthritis during treatment with tocilizumab
004004 (2009) Shin-Ya Kawashiri [Japon] ; Atsushi Kawakami [Japon] ; Satoshi Yamasaki [Japon] ; Takahiro Imazato [Japon] ; Naoki Iwamoto [Japon] ; Keita Fujikawa [Japon] ; Toshiyuki Aramaki [Japon] ; Mami Tamai [Japon] ; Hideki Nakamura [Japon] ; Hiroaki Ida [Japon] ; Tomoki Origuchi [Japon] ; Yukitaka Ueki [Japon] ; Katsumi Eguchi [Japon]Effects of the anti-interleukin-6 receptor antibody, tocilizumab, on serum lipid levels in patients with rheumatoid arthritis
004046 (2009) Shin-Ya Kawashiri [Japon] ; Atsushi Kawakami [Japon] ; Naoki Iwamoto [Japon] ; Keita Fujikawa [Japon] ; Toshiyuki Aramaki [Japon] ; Mami Tamai [Japon] ; Kazuhiko Arima [Japon] ; Makoto Kamachi [Japon] ; Satoshi Yamasaki [Japon] ; Hideki Nakamura [Japon] ; Toshiyuki Tsurumoto [Japon] ; Masafumi Kono [Japon] ; Hiroyuki Shindo [Japon] ; Hiroaki Ida [Japon] ; Tomoki Origuchi [Japon] ; Katsumi Eguchi [Japon]Proinflammatory Cytokines Synergistically Enhance the Production of Chemokine Ligand 20 (CCL20) from Rheumatoid Fibroblast-like Synovial Cells in vitro and Serum CCL20 Is Reduced in vivo by Biologic Disease-modifying Antirheumatic Drugs
004348 (????) Shin-Ya Kawashiri [Japon] ; Ayako Nishino [Japon] ; Takahisa Suzuki [Japon] ; Yoshikazu Nakashima [Japon] ; Yoshiro Horai [Japon] ; Yukitaka Ueki [Japon] ; Toshiyuki Aramaki [Japon] ; Keita Fujikawa [Japon] ; Munetoshi Nakashima [Japon] ; Akitomo Okada [Japon] ; Kiyoshi Migita [Japon] ; Akinari Mizokami [Japon] ; Naoki Matsuoka [Japon] ; Masanobu Mine [Japon] ; Soko Sakito [Japon] ; Naoki Iwamoto [Japon] ; Kunihiro Ichinose [Japon] ; Mami Tamai [Japon] ; Hideki Nakamura [Japon] ; Tomoki Origuchi [Japon] ; Kiyoshi Aoyagi [Japon] ; Katsumi Eguchi [Japon] ; Atsushi Kawakami [Japon]Rapid improvement of Clinical Disease Activity Index (CDAI) at 3 months predicts a preferable CDAI outcome at 1 year in active rheumatoid arthritis patients treated with tocilizumab: results from an observational investigation of daily clinical practice.
004382 (????) Keita Fujikawa [Japon] ; Kiyoshi Migita ; Toshiaki Tsukada ; Masataka Umeda ; Fumiaki Nonaka ; Atsushi Kawakami ; Katsumi EguchiInterleukin-6 targeting therapy in familial Mediterranean fever.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Author.i -k "Atsushi Kawakami" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Author.i  \
                -Sk "Atsushi Kawakami" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    Author.i
   |clé=    Atsushi Kawakami
}}

Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021